I just want to clarify. The two layers you're referring to are the regulation of drugs and then the reimbursement. Those are the two layers? That's what I was checking on. Yes, you were talking about two different layers, I think.
Having two layers that deal with regulation and reimbursement is pretty standard practice across the world. Regulation gives permission to market and sell a product, which a citizen may buy, and that is separate from any system that has publicly funded drugs, whereby those paying for those publicly funded drugs would have a system in place to determine which of those that are marketable they will pay for. That's standard in any publicly funded health care system, yes.